We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

49 hedge funds and large institutions have $15.4M invested in Anixa Biosciences in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

676% more call options, than puts

Call options by funds: $194K | Put options by funds: $25K

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

20% more funds holding

Funds holding: 41 → 49 (+8)

0.53% more ownership

Funds ownership: 11.33% → 11.86% (+0.53%)

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

10% less capital invested

Capital invested by funds: $17.1M → $15.4M (-$1.73M)

Holders
49
Holders Change
+8
Holders Change %
+19.51%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
11
Reduced
12
Closed
2
Calls
$194K
Puts
$25K
Net Calls
+$169K
Net Calls Change
+$134K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$150K
2
Stifel Financial
Stifel Financial
Missouri
+$144K
3
Citadel Advisors
Citadel Advisors
Florida
+$134K
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$121K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$109K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$178K
2
SWM
Spire Wealth Management
Virginia
-$57.7K
3
Renaissance Technologies
Renaissance Technologies
New York
-$44.7K
4
RJA
Raymond James & Associates
Florida
-$17.5K
5
BlackRock
BlackRock
New York
-$15.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
KeyBank National Association
26
KeyBank National Association
Ohio
$65.9K – – –
CAM
27
Concorde Asset Management
Michigan
$65.9K -$2.29K -475 -3%
BRWA
28
B. Riley Wealth Advisors
Florida
$64.6K -$4.81K -1,000 -6%
NFG
29
Nations Financial Group
Iowa
$55.3K +$62.5K +13,000 New
Charles Schwab
30
Charles Schwab
California
$54.3K – – –
IAIM
31
International Assets Investment Management
Florida
$46.8K +$52.9K +11,000 New
ATC
32
Adirondack Trust Company
New York
$29.8K – – –
First Manhattan
33
First Manhattan
New York
$27.6K – – –
FWA
34
Freedom Wealth Alliance
Wisconsin
$23.2K +$26.2K +5,453 New
TWM
35
Tradition Wealth Management
Minnesota
$21K – – –
SWM
36
Spire Wealth Management
Virginia
$11K -$57.7K -12,000 -83%
Wells Fargo
37
Wells Fargo
California
$7.26K +$4.84K +1,007 +143%
AA
38
Ancora Advisors
Ohio
$6K -$2.4K -500 -25%
Osaic Holdings
39
Osaic Holdings
Arizona
$4K -$481 -100 -10%
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$4K +$87 +18 +2%
JP Morgan Chase
41
JP Morgan Chase
New York
$3K – – –
ASN
42
Advisory Services Network
Georgia
$2.87K +$3.24K +674 New
LFG
43
Larson Financial Group
Missouri
$2.23K – – –
US Bancorp
44
US Bancorp
Minnesota
$1.7K – – –
TRCT
45
Tower Research Capital (TRC)
New York
$1K +$976 +203 New
Carson Wealth (CWM LLC)
46
Carson Wealth (CWM LLC)
Nebraska
$1K +$1.2K +250 New
BC
47
Barrett & Company
Rhode Island
$340 – – –
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
$90 – – –
TAM
49
Tucker Asset Management
Colorado
$42 -$433 -90 -90%
Millennium Management
50
Millennium Management
New York
– -$178K -36,249 Closed
1
2
3

ANIX Hedge Fund Activity: Q4 2022 in Review

49 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q4 2022, worth a combined $15.4M — down 10% from $17.1M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ANIX positions and 2 closed out — a net gain of 8 holders — while 11 added to existing stakes and 12 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $150K. The largest seller was Millennium Management, exiting entirely with an estimated $178K sold.

  • 49 institutional investors held Anixa Biosciences (ANIX) as of Q4 2022, up from 41 in Q3 2022.
  • Funds reported $15.4M of Anixa Biosciences stock for Q4 2022, down 10% quarter-over-quarter.
  • 10 funds opened new Anixa Biosciences positions in Q4 2022 and 2 closed out, a net change of +8 holders.
  • The largest Anixa Biosciences buyer in Q4 2022 was Susquehanna International Group, an estimated $150K added.
  • The largest Anixa Biosciences seller in Q4 2022 was Millennium Management, an estimated $178K sold.

Based on aggregated 13F filings for Q4 2022.